Mild COVID-19 Symptoms in an Infliximab-Treated Ulcerative Colitis Patient: Can Ongoing Anti-TNF Therapy Protect against the Viral Hyperinflammatory Response and Avoid Aggravated Outcomes?-Reference-Cited by-同舟云学术

Mild COVID-19 Symptoms in an Infliximab-Treated Ulcerative Colitis Patient: Can Ongoing Anti-TNF Therapy Protect against the Viral Hyperinflammatory Response and Avoid Aggravated Outcomes?

Published:2020 Issue:4 Volume:36 Page:338-342
ISSN:2297-4725
Container-title:Visceral Medicine
language:en
Short-container-title:Visc Med

Author:

Abdullah Abdullah,Neurath Markus F.,Atreya Raja

Publisher

S. Karger AG

Subject

Gastroenterology,Surgery

Reference23 articles.

1. Wu F, Zhao S, Yu B, Chen YM, Wang W, Song ZG, et al. A new coronavirus associated with human respiratory disease in China. Nature. 2020 Mar;579(7798):265–9.

2. Guan WJ, Ni ZY, Hu Y, Liang WH, Ou CQ, He JX, et al.; China Medical Treatment Expert Group for Covid-19. Clinical Characteristics of Coronavirus Disease 2019 in China. N Engl J Med. 2020 Apr;382(18):1708–20.

3. Colombel JF, Sandborn WJ, Reinisch W, Mantzaris GJ, Kornbluth A, Rachmilewitz D, et al.; SONIC Study Group. Infliximab, azathioprine, or combination therapy for Crohn’s disease. N Engl J Med. 2010 Apr;362(15):1383–95.

4. Atreya R, Neumann H, Neufert C, Waldner MJ, Billmeier U, Zopf Y, et al. In vivo imaging using fluorescent antibodies to tumor necrosis factor predicts therapeutic response in Crohn’s disease. Nat Med. 2014 Mar;20(3):313–8.

5. Rahier JF, Magro F, Abreu C, Armuzzi A, Ben-Horin S, Chowers Y, et al.; European Crohn’s and Colitis Organisation (ECCO). Second European evidence-based consensus on the prevention, diagnosis and management of opportunistic infections in inflammatory bowel disease. J Crohns Colitis. 2014 Jun;8(6):443–68.

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Protective role of flavonoids quercetin and silymarin in the viral-associated inflammatory bowel disease: an updated review;Archives of Microbiology;2023-05-30

2. The Impact of COVID-19 on the Cardiovascular Health of Emerging Adults Aged 18-25: Findings From a Scoping Review;CJC Pediatric and Congenital Heart Disease;2023-02

3. Carotenoids as potential inhibitors of TNFα in COVID-19 treatment;PLOS ONE;2022-12-27

4. Treatment of severe COVID-19: an evolving paradigm;Expert Opinion on Pharmacotherapy;2022-10-28

5. COVID-19 in Children With Inflammatory Bowel Disease: A Systematic Review;Journal of Pediatrics Review;2022-10-01